Optimizing zirconia: the challenge of surface bioactivity

While yttria-stabilized zirconia exhibits mechanical properties comparable to titanium, its biological inertia still limits its optimal integration with bone tissues. This experimental study specifically addresses this clinical hurdle by evaluating an innovative dual-layer coating combining nano-fluorapatite and nano-chitosan (nFA/nCS). The objective is twofold: to transform the zirconia surface to promote osseointegration while conferring intrinsic antimicrobial properties.

Researchers tested the hypothesis that sol-gel functionalization could radically modify surface physico-chemistry. The results confirm this mutation: the coating, with a precise thickness of 9.26 μm, increased the surface roughness to 121.3 nm. Notably for the practitioner, wettability was transfigured, with the water contact angle dropping to only 5°, a sign of super-hydrophilicity conducive to cell adhesion. With an adhesion strength of 0.50 ± 1.1 N/mm and increased resistance to ultrasonic delamination, this nFA/nCS complex positions itself as a credible technological alternative for optimizing the biological performance of zirconia implants.

Study methodology

This in vitro experimental study evaluated the performance of an innovative bi-layer coating combining nano-fluorapatite and nano-chitosan (nFA/nCS) on yttria-stabilized zirconia substrates.

The research protocol followed several stages of characterisation and biological testing:

• Coating synthesis: Application of an nFA/nCS bi-layer using the sol-gel method on zirconia discs, resulting in a final thickness of 9.26 μm.
• Physico-chemical characterization: Integrity and topography were analyzed by X-ray diffraction (XRD), atomic force microscopy (AFM) and scanning electron microscopy (FE-SEM/EDS). The surface roughness was measured at 121.3 nm.
• Adhesion and wettability tests: Adhesion strength was evaluated by tape test (0.50 ± 1.1 N/mm) and resistance to ultrasonic vibrations. Wettability was determined by measuring the optical contact angle (reduced to 5°).
• Biological analyses:
  • Antimicrobial activity: Tests on S. aureus and E. coli strains.
  • Cytotoxicity: Evaluation of viability on osteoblast-like cells.

The experimental design compared the uncoated zirconia samples with the single nFA coating samples and the new nFA/nCS bi-layer coating.

Physico-chemical characteristics: a transformed surface

The application of the nFA/nCS bi-layer coating via the sol-gel process radically modifies the surface state of the zirconia. Atomic force microscopy (AFM) and scanning electron microscopy (FE-SEM/EDS) analyses confirm the integrity and homogeneity of the deposited layer.

Measured parameter	Value (nFA/nCS)	Potential clinical impact
Coating thickness	9.26 μm	Structural stability without excessive bulk
Contact angle (wettability)	5°	Extreme hydrophilicity promoting protein adsorption
Surface roughness (Ra)	121.3 nm	Augmentation of the bone-implant contact surface
Adhesion (tape test)	0.50 ± 1.1 N/mm	Adhesion strength deemed acceptable

Notable fact: wettability drops dramatically to reach a contact angle of only 5°, transforming an initially hydrophobic zirconia surface into a highly bioactive interface.

Mechanical performance and coating stability

The stability of the dual-layer coating was tested using ultrasonic vibrations. The results indicate a significantly higher resistance to delamination for the nFA/nCS dual-layer complex compared to the single nano-fluorapatite (nFA) coating. This synergy between chitosan and fluorapatite reinforces the mechanical cohesion of the interface.

Biocompatibility and antimicrobial properties

Biological evaluation demonstrates that the coating fulfills the dual objective of cellular safety and bacterial protection:

• Antimicrobial activity: A significant reduction in the number of colonies was observed for both tested strains, Staphylococcus aureus and Escherichia coli.
• Cytotoxicity: Tests on osteoblast-type cells confirm the absence of toxicity for mammalian tissues, validating the biocompatibility of the device.

The integration of nano-chitosan thus confers intrinsic antibacterial properties to the material without compromising the viability of bone cells, a major asset for preventing early peri-implantitis.

A bioactive interface to overcome the inertia of zirconia

This study highlights a significant advancement for metal-free implantology: the functionalization of zirconia through a nano-fluorapatite/nano-chitosan (nFA/nCS) bi-layer coating. Clinically, the transition from an inert surface to a superhydrophilic interface (contact angle dropping to 5°) represents a major lever for promoting protein adsorption and initial clot stability. The increase in roughness to 121.3 nm, coupled with a coating thickness of 9.26 μm, optimizes potential anchoring where raw zirconia traditionally struggles to integrate with bone tissues.

The most promising aspect for the practitioner lies in the double action of the coating: increased bioactivity, confirmed by the absence of cytotoxicity on osteoblast-like cells, coupled with a significant antimicrobial effect against S. aureus and E. coli. This property could drastically reduce the risks of early bacterial colonization, a critical challenge during the healing phase.

However, the limitations of this in vitro study on zirconia discs must be highlighted. Although the coating adhesion (0.50 ± 1.1 N/mm) is superior to that of a single layer of nFA, it will need to be tested against real shear stresses during implant placement. While biological superiority is demonstrated here, mechanical resistance to insertion torque remains the next milestone to validate before considering widespread clinical application as a cost-effective alternative to titanium implants.

Cette étude expérimentale valide un revêtement bi-couche nFA/nCS de 9,26 µm d'épaisseur, augmentant la rugosité de la zircone à 121,3 nm et optimisant sa mouillabilité (angle de contact réduit à 5°). Les résultats montrent une adhésion mécanique stable (0,50 ± 1,1 N/mm) et une activité antimicrobienne efficace contre S. aureus et E. coli, sans aucune cytotoxicité pour les ostéoblastes.

In concrete terms, for the practitioner:

• Optimisation of osseointegration: Consider functionalised zirconia as a credible alternative to titanium, its treated surface now promoting superior cellular adhesion through its extreme wettability.
• Prevention of peri-implantitis: The chitosan coating provides additional biological safety thanks to its intrinsic antibacterial properties, limiting early bacterial colonization.
• Therapeutic accessibility: The sol-gel method used suggests a reduction in manufacturing costs, facilitating the integration of high-end ceramic implants into your daily treatment plans.

Technical lexicon of the study

Yttria-stabilized zirconia: High-performance ceramic material used for dental implants whose mechanical properties are close to those of titanium, but which requires surface modification to improve its osseointegration.

Nano-fluorapatite (nFA): Nanostructured coating agent synthesized to functionalize the zirconia surface, aiming to increase its bioactivity and bone integration potential.

Nano-chitosan (nCS): Biopolymer integrated into the coating for its antimicrobial properties and its ability to reinforce the structural adhesion of the surface layer onto the ceramic substrate.

Contact angle: Physical parameter measuring the wettability of a surface. In this study, the angle drops to 5° after treatment, indicating extreme hydrophilicity favorable to biological interactions.

Sol-gel process: Chemical synthesis process used to apply the nFA/nCS bi-layer coating on zirconia discs, allowing to obtain a precise thickness of 9.26 μm.

Adhesion strength: Value measuring the coating's resistance to detachment (established at 0.50 ± 1.1 N/mm), evaluated by tensile tests and ultrasonic vibrations to guarantee mechanical stability.

Cytotoxicity: Evaluation of the biological safety of the material. Tests conducted on osteoblast-type cells demonstrate that the nFA/nCS coating exhibits no toxicity to mammalian cells.

---

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all responsibility for the use of this information. This document is not intended for patients or the general public.